New RESPOND Trial Targets Depression Linked to Early Life Adversity and Hormonal Sensitivity
The RESPOND trial will test a novel twelve-week virtual psychotherapy combined with inflammation, epigenetic, and neurosteroid biomarker monitoring in forty ...
